SCHEMBL4606567

SCHEMBL4606567

CC#CCOc1nsc(-c2ccccc2Cl)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.38
L3MBTL1 Q9Y468 5/20 0.38
TDP1 Q9NUW8 2/20 0.38
KDM4E B2RXH2 7/20 0.34
HPGD P15428 5/20 0.34
KMT2A Q03164 4/20 0.34
HSD17B10 Q99714 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
HTT P42858 2/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.34
NPC1 O15118 2/20 0.33
CASP3 P42574 2/20 0.33
SENP8 Q96LD8 2/20 0.33
SENP7 Q9BQF6 2/20 0.33
SENP6 Q9GZR1 2/20 0.33
TP53 P04637 1/20 0.33
PKM P14618 1/20 0.33
CYP19A1 P11511 1/20 0.33
MAPT P10636 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4605401 0.88 ALDH1A1 (0.37) ALDH1A1L3MBTL1TDP1KDM4EHPGD
SCHEMBL4606677 0.85 ALDH1A1 (0.33) ALDH1A1KDM4EHSD17B10SMN1; SMN2NPC1
SCHEMBL4605578 0.81 ADORA3 (0.42) ALDH1A1KDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL4604558 0.72 CHRNA7 (0.38) KDM4ESMN1; SMN2
SCHEMBL6364194 0.69
SCHEMBL4606264 0.66 ADORA3 (0.45) ALDH1A1KDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL4604129 0.66 TRPM8 (0.39) ALDH1A1L3MBTL1KDM4EHPGDKMT2A
SCHEMBL4605715 0.65 HSP90AA1 (0.49) ALDH1A1L3MBTL1TDP1KDM4EHPGD
SCHEMBL4606713 0.63 PTGS2 (0.46) ALDH1A1L3MBTL1TDP1KDM4EHPGD
SCHEMBL4605030 0.63 ALDH1A1 (0.40) ALDH1A1L3MBTL1TDP1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1574505-B1 1,2,4-THIADIAZOLE COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2008-07-16 EP disclosed
US-7361675-B2 1,2,4-thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2008-04-22 US disclosed
US-20060167266-A1 1,2,4- thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-07-27 US disclosed
EP-1574505-A1 1,2,4-THIADIAZOLE COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2005-09-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167266-A1 1,2,4- thiadiazole compounds and use thereof CBR3, CBR1, NOX3 ALDH1A1 518/4885L3MBTL1 166/4885TDP1 2099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.